679 related articles for article (PubMed ID: 30236834)
1. Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection.
Chan AWH; Zhong J; Berhane S; Toyoda H; Cucchetti A; Shi K; Tada T; Chong CCN; Xiang BD; Li LQ; Lai PBS; Mazzaferro V; García-Fiñana M; Kudo M; Kumada T; Roayaie S; Johnson PJ
J Hepatol; 2018 Dec; 69(6):1284-1293. PubMed ID: 30236834
[TBL] [Abstract][Full Text] [Related]
2. The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection.
Lin CY; Lin CC; Wang CC; Chen CL; Hu TH; Hung CH; Huang PY; Tsai MC
World J Surg; 2020 Jan; 44(1):247-257. PubMed ID: 31559485
[TBL] [Abstract][Full Text] [Related]
3. Modified Child-Pugh grade
Huang F; Gao J
World J Gastroenterol; 2020 Feb; 26(7):749-758. PubMed ID: 32116422
[TBL] [Abstract][Full Text] [Related]
4. The combination of the preoperative albumin-bilirubin grade and the fibrosis-4 index predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
Zhang J; Luo Y; Li C; Liu J; Xiang H; Wen T
Biosci Trends; 2019; 13(4):351-357. PubMed ID: 31527331
[TBL] [Abstract][Full Text] [Related]
5. Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection.
Li C; Zhang XY; Peng W; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Chen LP
Medicine (Baltimore); 2018 Jul; 97(29):e11599. PubMed ID: 30024565
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
[TBL] [Abstract][Full Text] [Related]
7. Post-operative albumin-bilirubin grade predicts long-term outcomes among Child-Pugh grade A patients with hepatocellular carcinoma after curative resection.
Amisaki M; Uchinaka E; Morimoto M; Tokuyasu N; Sakamoto T; Honjo S; Saito H; Fujiwara Y
Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):502-509. PubMed ID: 30077606
[TBL] [Abstract][Full Text] [Related]
8. Albumin-bilirubin (ALBI) grade-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
Ho SY; Hsu CY; Liu PH; Hsia CY; Su CW; Huang YH; Hou MC; Huo TI
Eur J Surg Oncol; 2019 May; 45(5):776-781. PubMed ID: 30401507
[TBL] [Abstract][Full Text] [Related]
9. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
10. Combined Preoperative ALBI and FIB-4 Is Associated with Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy.
Liao R; Li DW; Du CY; Li M
J Gastrointest Surg; 2018 Oct; 22(10):1679-1687. PubMed ID: 29777455
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for early recurrence of HBV-related hepatocellular carcinoma meeting milan criteria after curative resection.
Zhu WJ; Huang CY; Li C; Peng W; Wen TF; Yan LN; Li B; Wang WT; Xu MQ; Yang JY; Jiang L
Asian Pac J Cancer Prev; 2013; 14(12):7101-6. PubMed ID: 24460258
[TBL] [Abstract][Full Text] [Related]
12. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
Oh IS; Sinn DH; Kang TW; Lee MW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Dig Dis Sci; 2017 Nov; 62(11):3235-3242. PubMed ID: 28983724
[TBL] [Abstract][Full Text] [Related]
13. Preoperative albumin-bilirubin grade combined with aspartate aminotransferase-to-platelet count ratio index predict outcomes of patients with hepatocellular carcinoma within Milan criteria after liver resection.
Luo H; Li C; Chen L
Biosci Trends; 2019 May; 13(2):176-181. PubMed ID: 31061272
[TBL] [Abstract][Full Text] [Related]
14. Postoperative Albumin-Bilirubin Grade Change Predicts the Prognosis of Patients with Hepatitis B-Related Hepatocellular Carcinoma Within the Milan Criteria.
Li C; Zhang XY; Peng W; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ
World J Surg; 2018 Jun; 42(6):1841-1847. PubMed ID: 29138913
[TBL] [Abstract][Full Text] [Related]
15. Surgical resection for hepatocellular carcinoma: clinical outcomes and safety in elderly patients.
Nishikawa H; Arimoto A; Wakasa T; Kita R; Kimura T; Osaki Y
Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):912-9. PubMed ID: 23470356
[TBL] [Abstract][Full Text] [Related]
16. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.
Ruan DY; Lin ZX; Wang TT; Zhao H; Wu DH; Chen J; Dong M; Lin Q; Wu XY; Li Y
Oncotarget; 2016 Sep; 7(38):61378-61389. PubMed ID: 27542216
[TBL] [Abstract][Full Text] [Related]
17. The role of preoperative albumin-bilirubin grade for oncological risk stratification in liver transplant patients with hepatocellular carcinoma.
Kornberg A; Witt U; Schernhammer M; Kornberg J; Müller K; Friess H; Thrum K
J Surg Oncol; 2019 Dec; 120(7):1126-1136. PubMed ID: 31578753
[TBL] [Abstract][Full Text] [Related]
18. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
[TBL] [Abstract][Full Text] [Related]
19. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
Lee S; Rhim H; Kim YS; Kang TW; Song KD
Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
[TBL] [Abstract][Full Text] [Related]
20. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]